Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of BCG Vaccination on Innate Immune Response in Healthy Volunteers
NCT02085590Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sepsis comparing BCG vaccine with Placebo (2 arms). Primary endpoint: Effects of gamma-irradiated BCG-vaccination on the in vivo innate immune responses induced by human endotoxemia at 1 month. Started Mar 2014; status: completed.
02
Drugs
bcg vaccine
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02085590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085590.